MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/vaccines13080877

Медицинская библиотека · Vaccines · 2025

Trends in DTP3 Vaccination in Asia (2012-2023).

Aguinaga-Ontoso Ines, Guillen-Aguinaga Laura, Guillen-Aguinaga Sara, Alas-Brun Rosa, Guillen-Aguinaga Miriam, Aguinaga-Ontoso Enrique, Onambele Luc, Guillen-Grima Francisco

СтатьяПеревод в очереди

Аннотация

BACKGROUND/

OBJECTIVES

DTP3 (diphtheria-tetanus-pertussis vaccine, third dose) coverage is a key indicator of the strength and continuity of routine immunization programs, which demonstrably reduces the burden of infectious diseases globally. This study aims to assess trends in DTP3 vaccination coverage across Asian regions and countries from 2012 to 2023, focusing on changes associated with the COVID-19 pandemic.

METHODS

DTP3 vaccination data were obtained from official WHO/UNICEF Estimates of National Immunization Coverage (WUENIC) and analyzed using Joinpoint regression to detect statistically significant changes in vaccination trends. Data were grouped by five Asian subregions based on the UN geoscheme (Central, Eastern, Southeastern, Southern, and Western Asia), and trends were weighted using birth cohort sizes. The presence of joinpoints and annual percentage changes (APCs) was calculated, and potential pandemic-related disruptions were contextualized.

RESULTS

At the continental level, Asia experienced a modest 0.4% annual increase in DTP3 coverage between 2012 and 2023, with a significant joinpoint detected in 2018. Following this, Southeast Asia's coverage declined at an annual rate of -4.32% before beginning to recover in 2021, while South Asia showed a similar pattern. Country-level analysis revealed significant heterogeneity, with a comparison between 2019 and 2023 showing profound post-pandemic declines in some nations, such as Lebanon (-21%) and Myanmar (-9.4%), while others, like Iraq and the Philippines, achieved substantial recoveries with coverage increasing by over 6 percentage points. These trends contrasted with persistent declines in fragile states (e.g., Afghanistan, Yemen) and sustained high coverage in others (e.g., Bangladesh, Israel). The pandemic, systemic weaknesses, emerging vaccine hesitancy, and misinformation were identified as key influences.

CONCLUSIONS

There is progress in DTP3 coverage across Asia. There were pandemic-related disruptions, particularly in regions with fragile health systems. Strategies to address zero-dose and dropout children, improve service continuity, and counter misinformation are essential to meet immunization targets under the Immunization Agenda 2030.

Для цитирования: Aguinaga-Ontoso Ines, Guillen-Aguinaga Laura, Guillen-Aguinaga Sara, Alas-Brun Rosa, Guillen-Aguinaga Miriam, Aguinaga-Ontoso Enrique, Onambele Luc, Guillen-Grima Francisco. Trends in DTP3 Vaccination in Asia (2012-2023).. Vaccines. 2025. DOI: 10.3390/vaccines13080877.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.